These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 1697284

  • 1. [Volume substitution in acute normovolemic hemodilution. 5% human albumin vs. 6% hydroxyethyl starch].
    von Bormann B, Sticher J, Ratthey K, Idelberger R, Hempelmann G.
    Infusionstherapie; 1990 Jun; 17(3):142-6. PubMed ID: 1697284
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Isovolemic hemodilution alters the ratio of whole-body to large-vessel hematocrit (F-cell ratio). A prospective, randomized study comparing the volume effects of hydroxyethyl starch 200,000/0.62 and albumin.
    Haller M, Brechtelsbauer H, Akbulut C, Fett W, Briegel J, Finsterer U.
    Infusionsther Transfusionsmed; 1995 Apr; 22(2):74-80. PubMed ID: 7540445
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hydroxyethylstarch 200 and 240 differently affect aortic distensibility but not viscosity and blood pressure upon acute isovolumic hemodilution.
    Caron A, Hacquard M, Audibert G, Cauchois G, Vigneron C, Stoltz JF, Longrois D, Menu P.
    Clin Hemorheol Microcirc; 2006 Apr; 35(4):447-58. PubMed ID: 17148843
    [Abstract] [Full Text] [Related]

  • 13. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic hemodilution with middle molecular weight hydroxyethyl starch (Haes 200/0.62; 6 percent)].
    Jung F, Waldhausen P, Spitzer S, Mrowietz C, Häuser B, Wenzel E.
    Infusionstherapie; 1988 Dec; 15(6):265-71. PubMed ID: 2466797
    [Abstract] [Full Text] [Related]

  • 14. [A comparison of autologous transfusion procedures in hip surgery].
    Lorentz A, Osswald PM, Schilling M, Jani L.
    Anaesthesist; 1991 Apr; 40(4):205-13. PubMed ID: 2058822
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W.
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Hemorheologic, micro- and macrocirculatory effects of an infusion of 500 ml of 6% medium molecular weight hydroxyethyl starch (Haes 200,000/0.5)].
    Jung F, Waldhausen P, Mrowietz C, Spitzer S, Kiesewetter H, Wenzel E.
    Infusionstherapie; 1989 Aug; 16(4):148-54. PubMed ID: 2478482
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Limitations of blood conservation.
    Weisel RD, Charlesworth DC, Mickleborough LL, Fremes SE, Ivanov J, Mickle DA, Teasdale SJ, Glynn MF, Scully HE, Goldman BS.
    J Thorac Cardiovasc Surg; 1984 Jul; 88(1):26-38. PubMed ID: 6376959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.